more>SIPCD Snapshots

Invited Speakers



Youngro Byun

Youngro Byun

 

Professor, Department of Molecular Medicine and Biopharmaceutical Science, Graduate School of Convergence Science and Technology, Seoul National University

Professor, College of Pharmacy, Seoul National University

 

Group Website:

http://www. snupharm.ac.kr/yrbyun/

 

 He received Ph.D. in the department of pharmaceutics and pharmaceutical sciences, University of Utah in 1994. He had worked in the department of pharmaceutics, University of Michigan as a postdoctoral fellow from 1994 to 1996. From 1996 to 2005, he had worked in the department of materials science and engineering, Gwangju Institute of Science and Technology as an assistant/associate professor. In 2005, he joined the faculty at the college of pharmacy, Seoul National University. His researches are focused on oral macromolecule delivery, induced phenotype targeted therapy and metronomic chemotherapy. Especially, his research is expanded to the new strategy for cancer therapy, that is, blood perfusion and cancer. He published more than 200 papers and filed above 40 international patents. He has served as a handling editor of Biomaterials, and as an editorial member of Journal of Controlled Release and Pharmaceutical Research. He has also severed as Mediator in a Patent Court of Law in Korea and a Member of National Pharmacy Deliberation Committee in Korea.

 

Representative Publications

[1]     H. Park, Y Byun, et al, Polymeric nano-shielded islets with heparin-polyethylene glycol in a non-human primate model. Biomaterials 171 164-177 (2018)

[2]     S.W. Chung, Y. Byun, et al, Self-triggered apoptosis enzyme prodrug therapy (STAEPT): Enhancing targeted therapies via recurrent bystander killing effect by exploiting caspase-cleavable linker. Adv. Sci. (2018) (1 800 368)  

[3]     S.W. Chung, Y. Byun, et al, Radiotherapy-assisted tumor selective metronomic oral chemotherapy. Int. J. Cancer 141 1912-1920 (2017)

[4]     F. Mahmud, Y. Byun, et al, Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer treatment. J. Control. Rel. 249 42-52 (2017)

[5]     M.R. Haque, Y. Byun, et al, Combination strategy of multi-layered surface camouflage using hyperbranched polyethylene glycol and immunosuppressive drugs for the prevention of immune reactions against transplanted porcine islets. Biomaterials 84 144-156 (2016)

[6]     T.A. Al-Hilal, Y. Byun, et al, Targeting prion-like protein doppel selectively suppresses tumor angiogenesis. J. Clin. Invest. 126(4) 1251-1266 (2016) 


Soochow University Biomedical Polymers Laboratory 
199 Ren-Ai Road, Suzhou Industrial Park, Suzhou 215123, China